There haven't been many positive catalysts for MannKind Corporation (NASDAQ:MNKD) in a few months. The stock is down significantly so far in 2018 after starting off with some nice gains. But there was at least a chance for some good news when the company reported its first-quarter results after the market closed on Wednesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,